Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy

Author： Chen Hao Lin Zongtao Arnst Kinsie E. Miller Duane D. Li Wei

Publisher： MDPI

E-ISSN： 1420-3049|22|8|1281-1281

ISSN： 1420-3049

Source： Molecules, Vol.22, Iss.8, 2017-08, pp. : 1281-1281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody–Drug Conjugates for Cancer Therapy

By Parslow Adam C. Parakh Sagun Lee Fook-Thean Gan Hui K. Scott Andrew M.

Biomedicines, Vol. 4, Iss. 3, 2016-07 ,pp. : 14-14

MDPI

Access to resources Recommend Favorite

Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs)

By Yao Houzong Jiang Feng Lu Aiping Zhang Ge

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 194-194

MDPI

Access to resources Recommend Favorite

Linkers Having a Crucial Role in Antibody–Drug Conjugates

By Lu Jun Jiang Feng Lu Aiping Zhang Ge

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 561-561

MDPI

Access to resources Recommend Favorite

Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice

By Janthur Wolf-Dieter Cantoni Nathan Mamot Christoph

International Journal of Molecular Sciences, Vol. 13, Iss. 12, 2012-11 ,pp. : 16020-16045

MDPI

Access to resources Recommend Favorite

Design and Synthesis of Isosteviol Triazole Conjugates for Cancer Therapy

By Khaybullin Ravil N. Zhang Mei Fu Junjie Liang Xiao Li Tammy Katritzky Alan R. Okunieff Paul Qi Xin

Molecules, Vol. 19, Iss. 11, 2014-11 ,pp. : 18676-18689

MDPI

Access to resources Recommend Favorite